» Articles » PMID: 27435453

Associations of Vitamin D Deficiency and Vitamin D Receptor (Cdx-2, Fok I, Bsm I and Taq I) Polymorphisms with the Risk of Primary Open-angle Glaucoma

Overview
Journal BMC Ophthalmol
Publisher Biomed Central
Specialty Ophthalmology
Date 2016 Jul 21
PMID 27435453
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D deficiency and vitamin D receptor gene polymorphisms are known to be significantly associated with high myopia. Whether this genetic variant may impact primary open-angle glaucoma is largely unknown. This study investigated whether vitamin D receptor gene polymorphisms are altered in primary open-angle glaucoma subjects carrying the risk allele, and whether vitamin D deficiency is an important factor in the development of glaucoma.

Methods: Seventy-three POAG patients and 71 age-matched controls from the Han population were enrolled. Serum levels of 1a, 25-Dihydroxyvitamin D3 were measured by enzyme-linked immunoabsorbent assay. Vitamin D receptor polymorphisms (Cdx-2, Fok I, Bsm I and Taq I) were analyzed using real-time polymerase-chain reaction high resolution melting analysis.

Results: Serum levels of 1a, 25-Dihydroxyvitamin in primary open-angle glaucoma patients were lower than in age-matched controls. Statistical analysis revealed a significant difference in the allelic frequencies of the BsmI and TaqI genotypes between primary open-angle glaucoma patients and age-matched controls, while other polymorphisms did not show any significant differences.

Conclusions: Vitamin D deficiency and the presence of the BsmI 'B' allele and the TaqI 't' allele are relevant risk factors in the development of glaucoma.

Trial Registration: Clinical Trials.gov: NCT02539745 . The study was registered retrospectively on August 3rd, 2015. The first participant was enrolled on July 4th, 2013.

Citing Articles

The role of Vitamin D3 in ocular fibrosis and its therapeutic potential for the glaucomatous trabecular meshwork.

Morelli-Batters A, Lamont H, Elghobashy M, Masood I, Hill L Front Ophthalmol (Lausanne). 2024; 2:897118.

PMID: 38983544 PMC: 11182265. DOI: 10.3389/fopht.2022.897118.


The Role of Vitamin D3 in Ocular Diseases.

Mrugacz M, Pienczykowska K, Bryl A Nutrients. 2024; 16(12).

PMID: 38931233 PMC: 11206323. DOI: 10.3390/nu16121878.


Exploring the Influence of Genetic Variants , , and on COVID-19 Severity and Long-COVID-19 Symptoms.

Alhammadin G, Jarrar Y, Madani A, Lee S J Pers Med. 2023; 13(12).

PMID: 38138892 PMC: 10744884. DOI: 10.3390/jpm13121663.


Association of Vitamin D deficiency with primary glaucoma among Saudi population - A pilot study.

Bokhary K, Alqahtani L, Aljaser F, Abudawood M, Almubarak F, Algowaifly S Saudi J Ophthalmol. 2022; 35(4):299-303.

PMID: 35814994 PMC: 9266469. DOI: 10.4103/sjopt.sjopt_109_21.


Vitamin D, the Vitamin D Receptor, Calcitriol Analogues and Their Link with Ocular Diseases.

Caban M, Lewandowska U Nutrients. 2022; 14(11).

PMID: 35684153 PMC: 9183042. DOI: 10.3390/nu14112353.


References
1.
Morrison N, Shine J, Fragonas J, Verkest V, McMenemy M, Eisman J . 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science. 1989; 246(4934):1158-61. DOI: 10.1126/science.2588000. View

2.
Marcus M, de Vries M, Junoy Montolio F, Jansonius N . Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. Ophthalmology. 2011; 118(10):1989-1994.e2. DOI: 10.1016/j.ophtha.2011.03.012. View

3.
Asman P, Heijl A . Glaucoma Hemifield Test. Automated visual field evaluation. Arch Ophthalmol. 1992; 110(6):812-9. DOI: 10.1001/archopht.1992.01080180084033. View

4.
Fingert J . Primary open-angle glaucoma genes. Eye (Lond). 2011; 25(5):587-95. PMC: 3171270. DOI: 10.1038/eye.2011.97. View

5.
Allingham R, Wiggs J, Hauser E, Larocque-Abramson K, Santiago-Turla C, Broomer B . Early adult-onset POAG linked to 15q11-13 using ordered subset analysis. Invest Ophthalmol Vis Sci. 2005; 46(6):2002-5. PMC: 1389566. DOI: 10.1167/iovs.04-1477. View